William J. Powers, M.D.
Departments of Neurology and Radiology
Washington University School of Medicine
Stroke Center at Barnes-Jewish Hospital

Contents:

An Introduction to Heparin

• What is Heparin?
• Heparinoids and Low Molecular Weight Heparins
• Intravenous Heparin for Partial Stable Stroke

Clinical Trials of Anticoagulation in Acute Ischemic Stroke

• Recently Published Clinical Trials
  • International Stroke Trial
  • Hong Kong Nadroparin Trial
  • Trial of ORG 1072 in Acute Stroke Treatment

Additional Studies

• Fraxiparine in Ischemic Stroke Study
• Complications in Patients with Cerebrovascular Disease
• Anticoagulant Treatment in Progressing Stroke
• Anticoagulant Therapy in Thrombosis in Evolution
• Heparin Treatment of Progressing Stroke-I
• Heparin Treatment of Progressing Stroke-II

Additional Studies and Conclusions

• Cerebral Embolism Study Group
• International Stroke Trial
  • Atrial Fibrillation subgroup
• Trial of ORG 1072 in Acute Stroke Treatment
  • Cardioembolism subgroup
  • Retrospective Stroke Subtype Analysis
• Cardiac Embolism Conclusions 
• Summary

Appendix

• References

 

About this Presentation:

This presentation was written by Dr. William J. Powers, co-director of the Stroke Center at Barnes-Jewish Hospital and the Washington University School of Medicine.

Last Revised: March 26, 2001